Literature DB >> 36080238

Design, Synthesis and Structure-Activity Relationship of Novel Pinacolone Sulfonamide Derivatives against Botrytis cinerea as Potent Antifungal Agents.

Chaojie Liu1, Xiaofang Xiang1, Ying Wan1, Jia Yang1, Yufei Li1, Xinchen Zhang1, Zhiqiu Qi1, Lu He1, Wei Liu1, Xinghai Li1.   

Abstract

To develop new fungicides with high efficiency, 46 novel sulfonamide derivatives were designed and synthesized by introducing pinacolone fragment into chesulfamide which was used as lead compound. All compounds were characterized by 1H NMR, 13C NMR, and MS spectra, and the structure of compound P-27 was also confirmed by X-ray single crystal diffraction. It was found that a variety of compounds present excellent inhibitory effect against Botrytis cinerea. The inhibition rates of P-29 on tomato and strawberry were 90.24% (200 mg/L) and 100% (400 mg/L) in vivo respectively, which were better than the lead compound chesulfamide (59.23% on tomato seedlings and 29.63% on strawberries).

Entities:  

Keywords:  Botrytis cinerea; chesulfamide; pinacolone; sulfonamide; synthesis

Mesh:

Substances:

Year:  2022        PMID: 36080238      PMCID: PMC9458130          DOI: 10.3390/molecules27175468

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.927


1. Introduction

Botrytis cinerea is a serious and widespread plant disease in tomato, cucumber, eggplant, pepper, grape and strawberry, especially under the condition of protected cultivation [1]. The international fungicide resistance action committee (FRAC) classified the fungi as a pathogen at high risk of fungicide resistance. The resistance of Botrytis cinerea to fungicides is very serious all over the world, which leads to a reduction or even failure of the control effect of fungicides [2,3,4,5]. The development of fungicides with novel action mechanism is the key to control the resistance of fungicides [6,7,8]. Chesulfamide is a novel candidate fungicide with excellent control effect on Botrytis cinerea without interactive resistance to multiple commercial fungicides, such as carbendazim, diethofencarb, iprodione, and procymidone, showing that it has unique mechanism of action [9,10,11]. In our previous work, several novel compounds were discovered by replacing the cyclohexanone moiety in chesulfamide with benzocyclohexanone, cyclohexanone, cyclopropyl methyl ketone, and acetophenone, respectively, which all presented superb control effect against Botrytis cinerea [12,13,14] (Figure 1).
Figure 1

Structures of active compounds in previous work.

Pinacolone is an intermediate widely used in the synthesis of pesticides [15,16,17]. At present, more than 20 kinds of pesticides containing pinacolone fragment have been developed, among which triazole fungicides such as triazole, triadimefon, and paclobutrazol are the most widely used [18,19,20] (Figure 2). Hence, the design and synthesis of novel compounds containing the structure of pinacolone still has high value and broad prospect in the development of novel pesticide. In this work, chesulfamide was used as the lead compound, and novel sulfonamide derivatives were designed and prepared by replacing the cyclohexanone moiety with pinacolone group (Figure 3). The antifungal activity against Botrytis cinerea was investigated by the mycelium growth method and living pot method.
Figure 2

Agricultural active compounds containing pinacolone fragment.

Figure 3

Design strategy of the target compounds.

2. Results and Discussion

2.1. Chemistry

The synthetic route of the target compounds is shown in Scheme 1. Intermediate I was prepared from pinacolone by sulfonation with a sulfur trioxide-dioxane adduct and neutralization with potassium carbonate. Then, intermediate II was prepared by chlorination with oxalyl chloride. Finally, the target compounds were obtained by an amidation reaction with amines containing various substituents [21]. According to this synthetic method, 46 novel pinacolone sulfnamide derivatives were synthesized and their structures were characterized by 1H NMR, 13C NMR, and MS spectra (Supplementary Materials). Additionally, the structure of compound P-27 was also confirmed by X-ray single crystal diffraction (Figure 4).
Scheme 1

Synthetic route of the target compounds (Table 1).

Figure 4

X-ray single crystal diffraction of compound P-27.

2.2. Biological Assay

Table 1 summarizes the result of the in vitro antifungal spectrum of P-1~P-46, at a dosage of 50 mg/L against Rhizoctonia solani, Fusarium graminearum, Sclerotinia sclerotiorum, and Botrytis cinerea, which clearly shows that this series of compounds not only has good control effect on Botrytis cinerea, but also has good control effects on other pathogens. The inhibition rates of P-23 and P-30 against Botrytis cinerea were 86.44% and 93.35% (EC50 were 11.57 mg/L and 4.68 mg/L, Table 2), which were better than those of the lead compound chesulfamide.
Table 1

In vitro fungicidal activity of target compounds at 50 mg/L.

CompoundRInhibition rate(%)
R. solani F. graminearum S. sclerotiorum B. cinerea
P-1 CF3CH25.33 ± 5.314.17 ± 8.629.58 ± 00
P-2 033.09 ± 1.060 ± 25.80
P-3 CH3(CH2)3-19.8 ± 2.2133.82 ± 9.4600
P-4 CH3(CH2)4-26.65 ± 1.9821.81 ± 4.0925.83 ± 042.55 ± 2.17
P-5 CH3(CH2)5-010.78 ± 2.760 ± 3.0819.15 ± 1.59
P-6 2-F-C6H4-37.31 ± 2.6848.04 ± 0.2436.04 ± 2.3125.53 ± 1.06
P-7 3-F-C6H4-6.09 ± 2.869.56 ± 6.2806.38 ± 2.31
P-8 4-F-C6H4-12.94 ± 0.910.98 ± 4.6532.29 ± 5.848.51 ± 1.74
P-9 2-Cl-C6H4-20.3 ± 0.9111.76 ± 4.24022.87 ± 1.74
P-10 3-Cl-C6H4-39.34 ± 7.2522.06 ± 2.2077.92 ± 1.8132.45 ± 1.74
P-11 4-Cl-C6H4-36.29 ± 4.0823.53 ± 0025 ± 0.46
P-12 2-Br-C6H4-19.8 ± 2.9223.77 ± 0.9819.58 ± 0.7526.6 ± 0.46
P-13 3-Br-C6H4-9.64 ± 1.8336.76 ± 0.4283.75 ± 0.9534.04 ± 4.12
P-14 4-Br-C6H4-25.13 ± 0.5036.03 ± 0.7382.5 ± 3.8136.17 ± 0
P-15 2-OCH3-C6H4-9.14 ± 8.124.41 ± 2.9410.42 ± 4.160 ± 1.32
P-16 2-CF3-C6H4-33.76 ± 1.0132.6 ± 2.1355.83 ± 2.5241.76 ± 1.15
P-17 3-CF3-C6H4-42.89 ± 5.7632.6 ± 0.2436.67 ± 023.14 ± 0.46
P-18 4-OCF3-C6H4-49.49 ± 3.244.66 ± 0.2487.71 ± 1.1039.1 ± 0
P-19 4-Cl-2-F-C6H3-47.72 ± 2.6745.1 ± 1.0622.5 ± 1.8034.04 ± 4.79
P-20 4-Br-2-F-C6H3-2.54 ± 1.662.7 ± 2.330 ± 1.6247.34 ± 0.46
P-21 5-CF3-2-F-C6H3-37.31 ± 1.0140.93 ± 2.0990.42 ± 0.4136.97 ± 5.31
P-22 4-Br-3-F-C6H3-42.13 ± 8.6446.57 ± 1.6094.38 ± 0.5575 ± 2.81
P-23 2-CF3-4-Cl-C6H3-75.13 ± 2.1669.61 ± 1.0694.17 ± 0.6286.44 ± 2.31
P-24 5-CF3-2-Cl-C6H3-57.87 ± 0.4371.57 ± 2.7894.58 ± 1.1064.1 ± 3.06
P-25 4-Br-2-NO2-C6H3-53.81 ± 16.554.66 ± 0.2486.04 ± 9.5878.99 ± 0.53
P-26 3-Br-4-F-C6H3-19.8 ± 1.585.39 ± 0.4287.5 ± 027.66 ± 1.61
P-27 4-Br-3-CH3-C6H3-34.77 ± 1.7745.34 ± 2.4880 ± 2.3154.52 ± 5.07
P-28 2,4,5-F3-C6H2-36.8 ± 3.3130.39 ± 2.7636.88 ± 0.7522.07 ± 0.53
P-29 2,4,5-Cl3-C6H2-36.8 ± 1.7547.79 ± 0.4980.83 ± 12.253.46 ± 0.79
P-30 2,4,6-Br3-C6H2-81.47 ± 2.6762.01 ± 4.4997.92 ± 3.4793.35 ± 2.17
P-31 C6H5-CH2CH2-016.18 ± 1.366.25 ± 0.4139.63 ± 0.26
P-32 4-NO2-C6H4-CH2CH2-7.29 ± 3.5137.33 ± 4.7338.62 ± 6.4333.33 ± 1.15
P-33 4-CH3-C6H4-CH2CH2-22.92 ± 17.1022.67 ± 5.1351.32 ± 7.0914.18 ± 2.52
P-34 4-OCH3-C6H4-CH2CH2-40.63 ± 2.656.67 ± 4.0442.33 ± 5.5112.77 ± 4.36
P-35 3-OCH3-C6H4-CH2CH2-14.58 ± 2.0815.33 ± 3.5138.62 ± 6.6619.15 ± 2.65
P-36 3,4-(OCH3)2-C6H3-CH2CH2-04.67 ± 2.5232.28 ± 0.585.67 ± 4.62
P-37 4-F-C6H4-CH2CH2-12.50 ± 4.005.33 ± 4.1640.21 ± 6.5121.28 ± 0
P-38 3-F-C6H4-CH2CH2-10.94 ± 2.007.33 ± 3.7929.63 ± 5.7712.77 ± 5.29
P-39 2-F-C6H4-CH2CH2-9.38 ± 2.6510.67 ± 2.3140.74 ± 4.7315.60 ± 2.08
P-40 3-Br-C6H4-CH2CH2-44.79 ± 3.7932.00 ± 1.7331.75 ± 1.0025.53 ± 0
P-41 2-Br-C6H4-CH2-46.88 ± 1.0016.67 ± 0.5867.20 ± 3.2112.77 ± 3.61
P-42 4-F-C6H4-CH2-25.52 ± 2.0815.33 ± 3.2123.28 ± 6.4315.60 ± 2.08
P-43 2-F-C6H4-CH2-25.52 ± 2.0815.33 ± 3.2123.28 ± 6.439.93 ± 1.53
P-44 4-Cl-C6H4-CH2-16.15 ± 1.1527.33 ± 4.9321.69 ± 5.0327.66 ± 4.36
P-45 4-CN-C6H4-CH2-44.79 ± 16.8621.33 ± 1.1560.32 ± 6.2517.02 ± 5.20
P-46 2,5-(OCH3)-C6H4-CH2-54.69 ± 023.33 ± 5.5131.75 ± 024.11 ± 4.62
Chesulfamide/80.18 ± 0.2970.21 ± 1.2880.18 ± 0.2974.76 ± 4.61
Boscalid/85.28 ± 0.5051.23 ± 2.7298.33 ± 0.8398.28 ± 0
Table 2

EC50 of compounds against Botrytis cinerea.

CompoundEC50(95 Confidence Interval) (mg/L)Regression EquationR
P-22 >50Y = 3.4148 + 0.6774X0.9650
P-23 11.57(7.45–17.98)Y = 3.9031 + 1.0316X0.9810
P-25 39.00(27.22–55.88)Y = 2.2268 + 1.7430X0.9346
P-30 4.68(3.26–6.71)Y = 4.2520 + 1.1166X0.9648
Chesulfamide38.47(15.35–96.62)Y = 4.3874 + 0.4032X0.9179
Boscalid<0.2Y = 5.25981 + 0.2237X0.9514
In vitro fungicidal activity of target compounds at 50 mg/L. In the tomato pot experiment, it was found that the control effect of various compounds on Botrytis cinerea at 200 mg/L was better than that of chesulfamide, of which compound P-13 and P-29 were slightly weaker than the positive control boscalid, which were 91.22% and 90.04%, respectively (Table 3, Figure 5). In the strawberry experiment, compounds P-18, P-29, P-30 and P-31 exhibited higher antifungal activity against Botrytis cinerea than chesulfamide, especially compound P-29, which had a 100% inhibition rate at 400 mg/L (Table 4, Figure 6).
Table 3

Control efficacy of target compounds in tomato pot tests at 200 mg/L.

CompoundControl Efficacy %(Tomato Leaves)CompoundControl Efficacy %(Tomato Leaves)
P-1 26.83 abcP-2541.46 abc
P-2 70.73 abP-260
P-3 12.20 dP-270
P-4 0P-2841.82 abc
P-5 34.15 abcP-2990.24 a
P-6 0P-3041.46 abc
P-7 0P-3185.37 a
P-8 0P-320
P-9 12.20 dP-3374.35 ab
P-10 41.12 abcP-343.21 d
P-11 56.10 abcP-3558.78 abc
P-12 70.73 abP-3625.19 d
P-13 70.73 abP-3764.12 abc
P-14 76.59 abP-3867.48 abc
P-15 26.83 abcP-390
P-16 34.15 abcP-408.71 d
P-17 26.83 abcP-4160.00 abc
P-18 91.22 aP-4214.35 d
P-19 0P-4370.84 ab
P-20 48.78 abcP-440
P-21 78.05 abP-450
P-22 70.73 abP-4666.11 abc
P-23 26.83 abcchesulfamide59.23 abc
P-24 26.83 abcboscalid92.20 a

The letters a–d denote results with significant differences.

Figure 5

Tomato pot experiment.

Table 4

Control efficacy of some compounds in strawberry test at 400 mg/L.

CompoundControl Efficacy %(Strawberry)
P-18 73.33 a,b
P-23 0
P-29 100 a
P-30 66.67 a,b
P-31 88.89 a
Chesulfamide29.63 b,c
Boscalid94.07 a

The letters a–c denote results with significant differences.

Figure 6

Strawberry experiment.

2.3. Structure–Activity Relationship

Based on the result of antifungal activity experiments, the structure-activity relationship of target compounds can be concluded as follow. The order of substituent structures conducive to improving the activity of the compounds was phenyl (2,4,6-tribromophenyl is the best) > benzyl > phenylethyl > alkyl, which showed that phenyl can significantly improve the activity of the compound; and trisubstituted phenyl > disubstituted phenyl > monosubstituted phenyl. In the in vivo activity assay, compounds P-18, P-29 and P-31 had good antifungal activity, indicating that 4-trifluoromethoxyphenyl, 2,4,5-trichlorophenyl and phenylethyl had a positive effect on the activity of the compounds. The substituent of P-29 is 2,4,5-trichlorophenyl, which has been found to have a good control effect on Botrytis cinerea in previous studies [22,23]. Therefore, this substituent can be used as the active group for structure design in the future.

3. Materials and Methods

3.1. Instruments and Reagents

For all reactions, solvents and chemical reagents were purchased from commercial sources and used as received. All reactions were carried out under a nitrogen atmosphere unless noted. Reactions were monitored by thin layer chromatography (TLC) visualizing with ultraviolet light (UV) and phosphomolybdic acid (PMA) stain. Column chromatography purification was performed using silica gel. Proton nuclear magnetic resonance (1H NMR) spectra and carbon nuclear magnetic resonance (13C NMR) were recorded on a 600 MHz spectrometer in CDCl3 or DMSO-d6 as the solvent and TMS as the internal standard. NMR data were presented as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad), coupling constant in Hertz (Hz), integration. High-resolution mass spectrometry (HRMS) data were obtained on an Agilent 1290-6540B Q-TOF instrument. Single crystal structure analysis was performed using X-ray diffraction on a Rigaku Oxford Diffraction Supernova Dual Source diffractometer.

3.2. General Synthetic Procedures

Synthesis of intermediate I. A mixture of pinacolone (1 mol) in DCE (300 mL) was stirred in a dry flask under nitrogen atmosphere at 0 °C. Then, the trioxide-dioxane adduct (1 mol) was slowly added into the flask, and the reaction mixture was stirred for 3 h. CaCO3 was slowly added to adjust the pH of the reaction mixture to 7. The mixture was then filtered and the pH of the mixture was adjusted to 9 by K2CO3, then filtered. The aqueous layer was collected and distilled to give the intermediate I. Synthesis of intermediate II. Under the condition of ice bath, oxalyl chloride (20.6 mmol) was slowly added into the mixture of intermediate I (13.7 mmol), CH2Cl2 (40 mL) and DMF (0.54 mL), and the mixture was stirred for 3 h. Finally, a yellow liquid as obtained by suction filtration. Synthesis of target compounds. A mixture of amine (9.6 mmol), CH2Cl2 (40 mL), Et3N (1.2 mL) was stirred in a dry flask in an ice-bath. Then, intermediate II (9.6 mmol) was added dropwise and the mixture was reacted for 3h. Upon completion, the mixture was filtered and extracted with DCM, washed with brine, dried over Na2SO4, concentrated in vacuo and purified by silica column chromatography (PE:EA = 10:1, v/v ) to give target compounds. The spectral data of the Compound P-1~P-46 are described below. Data for 3,3-dimethyl-2-oxo-N-(3,3,3-trifluoroethyl)butane-1-sulfonamide (P-1): Yield 38%; white solid; m.p. 121.5–123.1 °C. 1H-NMR (600 MHz, DMSO-d6) δ 8.15 (t, J = 6.7 Hz, 1H, SO2-NH)), 4.62–4.58 (m, 2H, SO2-CH2), 3.79 (qd, J = 9.4, 6.5 Hz, 2H, N-CH2), 1.11 (d, J = 0.9 Hz, 9H, CH3).13C-NMR (151 MHz, DMSO-d6) δ 204.93, 124.34 (q, 1JFC = 278.53 Hz, CF3), 57.48, 44.56, 43.65 (q, 2JFC = 34.09 Hz), 25.18. EIMS calcd. for C8H15F3NO3S ([M + H]+): 262.07, found 260.00. Data for N-cyclopropyl-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-2): Yield 15%; white solid; m.p. 72.0–73.6 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.47 (d, J = 2.8 Hz, 1H, SO2-NH), 4.48 (s, 2H, SO2-CH2), 2.52 (m, 1H, N-CH), 1.12 (d, J = 0.7 Hz, 9H, CH3), 0.64–0.54 (m, 4H, CH2).13C-NMR (151 MHz, DMSO-d6) δ204.82, 55.34, 44.63, 25.30, 24.09, 5.37. HRMS calcd. for C9H18NO3S ([M + H]+): 220.1002, found 220.1000. Data for N-butyl-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-3): Yield 47%; white solid; m.p. 59.1–60.7 °C. 1H-NMR (600 MHz, DMSO-d6) δ7.02 (t, J = 5.9 Hz, 1H, SO2-NH), 4.41 (s, 2H, SO2-CH2), 2.94 (td, J = 7.2, 5.9 Hz, 2H, N-CH2), 1.43 (m, 2H, CH2), 1.30 (t, J = 7.3 Hz, 2H, CH2), 1.10 (s, 9H, CH3), 0.87 (t, J = 7.4 Hz, 3H, CH3).13C-NMR (151 MHz, DMSO-d6) δ 204.99, 55.87, 44.58, 31.47, 28.22, 25.28, 19.26, 13.52. HRMS calcd. for C10H22NO3S ([M + H]+): 236.1315, found 236.1319. Data for 3,3-dimethyl-2-oxo-N-pentylbutane-1-sulfonamide (P-4): Yield 51%; white solid; m.p. 52.2–54.2 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.02 (t, J = 5.9 Hz, 1H, SO2-NH), 4.41 (s, 2H, SO2-CH2), 2.93 (td, J = 7.2, 6.0 Hz, 2H, N-CH2), 1.45 (q, J = 7.2 Hz, 2H, CH2), 1.27 (m, 4H, CH2), 1.10 (s, 9H, CH3), 0.86 (t, J = 6.8 Hz, 3H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 206.23, 54.27, 45.34, 43.72, 29.48, 28.68, 25.63, 22.19, 13.91. HRMS calcd. for C11H24NO3S ([M + H]+): 250.1471, found 250.1479. Data for N-hexyl-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-5): Yield 22%; white solid; m.p. 59.2–60.2 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.02 (t, J = 5.9 Hz, 1H, SO2-NH), 4.41 (s, 2H, SO2-CH2), 2.93 (td, J = 7.2, 5.9 Hz, 2H, N-CH2), 1.43 (q, J = 7.2 Hz, 2H, CH2), 1.35–1.17 (m, 6H, CH2), 1.10 (s, 9H, CH3), 0.86 (t, J = 6.9 Hz, 3H, CH3).13C-NMR (151 MHz, DMSO-d6) δ 204.97, 55.90, 44.57, 42.59, 30.83, 29.35, 25.76, 25.28, 22.01, 13.87. HRMS calcd. for C12H26NO3S ([M + H]+): 264.1628, found 264.1629. Data for N-(2-fluorophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-6): Yield 79%; white solid; m.p. 126.8–128.6 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.75 (s, 1H, SO2-NH), 7.61 (dd, J = 9.9, 2.1 Hz, 2H, C6H4-H), 7.43–7.35 (m, 2H, C6H4-H), 4.61 (s, 2H, SO2-CH2), 1.08 (s, 9H, CH3). 13C NMR (151 MHz, DMSO-d6) δ 204.24, 155.39 (d, 1J = 251.79 Hz, F-Ph), 127.77 (d, 3J = 3.64 Hz), 127.68, 124.53 (d, 2J = 12.64 Hz), 119.38 (d, 2J = 23.46 Hz), 117.84 (d, 3J = 8.89 Hz), 57.05, 44.62, 25.23. HRMS calcd. for C12H17FNO3S ([M + H]+): 274.0908, found 274.0907. Data for N-(3-fluorophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-7): Yield 50%; white solid; m.p. 100.9–102.0 °C. 1H-NMR (600 MHz, DMSO-d6) δ 10.17 (s, 1H, SO2-NH), 7.35 (m, 1H, C6H4-H), 7.08–7.00 (m, 2H, C6H4-H), 6.94–6.88 (m, 1H, C6H4-H), 4.59 (s, 2H, SO2-CH2), 1.04 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 205.89, 163.12 (d, 1J = 247.2 Hz, F-Ph), 138.07 (d, 2J = 10.2 Hz), 130.80 (d, 3J = 9.41 Hz), 117.48 (d, 3J = 3.03 Hz), 112.98 (d, 2J = 21.32 Hz), 109.43 (d, 2J = 25.35 Hz), 53.15, 45.44, 25.52. HRMS calcd. for C12H17FNO3S ([M + H]+): 274.0908, found 274.0907. Data for N-(4-fluorophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-8): Yield 51%; white solid; m.p. 125.1–125.6 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.85 (s, 1H, SO2-NH), 7.30- 7.23 (m, 2H, C6H4-H4), 7.19 (t, J = 8.8 Hz, 2H, C6H4-H), 4.46 (s, 2H, SO2-CH2), 1.05 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 206.19, 161.10 (d, 1J = 246.23 Hz, F-Ph), 132.30 (d, 3J = 3.02 Hz), 124.97 (d, 3J = 8.36 Hz), 116.38 (d, 2J = 22.71 Hz), 52.63, 45.45, 25.54. HRMS calcd. for C12H17FNO3S ([M + H]+): 274.0908, found 274.0905. Data for N-(2-chlorophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-9): Yield 15%; white solid; m.p. 80.4–82.3 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.37 (s, 1H, SO2-NH), 7.51 (m, 2H, C6H4-H), 7.35 (td, J = 7.7, 1.5 Hz, 1H, C6H4-H), 7.26 (td, J = 7.7, 1.6 Hz, 1H, C6H4-H), 4.63 (s, 2H, SO2-CH2), 1.08 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.29, 133.81, 129.84, 128.71, 127.81, 127.39, 127.22, 57.78, 44.59, 25.31. HRMS calcd. for C12H17ClNO3S ([M + H]+): 290.0612, found 290.0614. Data for N-(3-chlorophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-10): Yield 40%; white solid; m.p. 108.7–111.5 °C. 1H-NMR (600 MHz, DMSO-d6) δ 10.16 (s, 1H, SO2-NH), 7.36 (t, J = 8.1 Hz, 1H, C6H4-H), 7.27 (d, J = 2.1 Hz, 1H, C6H4-H), 7.20 (m, 1H, C6H4-H), 7.16 (m, 1H, C6H4-H), 4.59 (s, 2H, SO2-CH2), 1.05 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 205.94, 137.67, 135.20, 130.59, 126.34, 122.23, 120.32, 53.14, 45.46, 25.53. HRMS calcd. for C12H17ClNO3S ([M + H]+): 290.0612, found 290.0603. Data for N-(4-chlorophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-11): Yield 45%; white solid; m.p. 112.4–114.1 °C. 1H-NMR (600 MHz, DMSO-d6) δ 10.03 (s, 1H, SO2-NH), 7.41–7.36 (m, 2H, C6H4-H), 7.26–7.22 (m, 2H, C6H4-H), 4.52 (s, 2H, SO2-CH2), 1.04 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 206.03, 134.99, 131.97, 129.69, 123.89, 77.26, 77.05, 76.84, 52.81, 45.46, 25.53. HRMS calcd. for C12H17ClNO3S ([M + H]+): 290.0612, found 290.0609. Data for N-(2-bromophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-12): Yield 31%; white solid; m.p. 92.9–94.1 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.26 (s, 1H, SO2-NH), 7.68 (dd, J = 8.0, 1.4 Hz, 1H, C6H4-H), 7.50 (dd, J = 8.0, 1.6 Hz, 1H, C6H4-H), 7.40 (td, J = 7.7, 1.5 Hz, 1H, C6H4-H), 7.19 (td, J = 7.7, 1.6 Hz, 1H, C6H4-H), 4.64 (s, 2H, SO2-CH2), 1.09 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.32, 135.16, 133.09, 128.43, 127.83, 127.46, 119.76, 57.98, 44.61, 25.32. EIMS calcd. for C12H17BrNO3S ([M + H]+): 334.01, found 333.90. Data for N-(3-bromophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-13): Yield 26%; white solid; m.p. 114.5–115.5 °C. 1H-NMR (600 MHz, DMSO-d6) δ 10.13 (s, 1H, SO2-NH), 7.40 (d, J = 2.2 Hz, 1H, C6H4-H), 7.32–7.25 (m, 1H, C6H4-H), 7.28 (s, 1H, C6H4-H), 7.24 (dt, J = 6.0, 2.5 Hz, 1H, C6H4-H), 4.58 (s, 2H, SO2-CH2), 1.04 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.20, 139.59, 131.11, 126.36, 121.83, 121.79, 118.26, 55.36, 44.72, 25.06. HRMS calcd. for C12H17BrNO3S ([M + H]+): 334.0107, found 334.0108. Data for N-(4-bromophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-14): Yield 38%; white solid; m.p. 112.1–113.5 °C. 1H-NMR (600 MHz, DMSO-d6) δ 10.04 (s, 1H, SO2-NH), 7.54–7.48 (m, 2H, C6H4-H), 7.21–7.15 (m, 2H, C6H4-H), 4.53 (s, 2H, SO2-CH2), 1.04 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.19, 137.34, 131.95, 121.65, 115.88, 55.10, 44.70, 25.08. EIMS calcd. for C12H17BrNO3S ([M + H]+): 334.01, found 333.90. Data for N-(2-methoxyphenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-15): Yield 14%; white solid; m.p. 70.0–71.1 °C. 1H-NMR (600 MHz, DMSO-d6) δ 8.72 (s, 1H, SO2-NH), 7.31 (dd, J = 7.9, 1.6 Hz, 1H, C6H4-H), 7.22–7.16 (m, 1H, C6H4-H), 7.07 (dd, J = 8.2, 1.3 Hz, 1H, C6H4-H), 6.94 (td, J = 7.6, 1.3 Hz, 1H, C6H4-H), 4.54 (s, 2H, SO2-CH2), 3.82 (s, 3H), 1.07 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.39, 149.67, 126.04, 125.65, 121.29, 120.82, 111.10, 56.00, 54.17, 45.13, 25.71. HRMS calcd. for C13H20NO4S ([M + H]+): 286.1108, found 286.1109. Data for 3,3-dimethyl-2-oxo-N-(2-(trifluoromethyl)phenyl)butane-1-sulfonamide (P-16): Yield 61%; white solid; m.p. 78.3–79.3 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.38 (s, 1H, SO2-NH), 7.75 (dd, J = 7.9, 1.5 Hz, 1H, C6H4-H), 7.71 (td, J = 7.7, 1.5 Hz, 1H, C6H4-H), 7.65 (d, J = 8.0 Hz, 1H, C6H4-H), 7.50 (t, J = 7.7 Hz, 1H, C6H4-H), 4.70 (s, 2H, SO2-CH2), 1.13 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.67, 133.97, 133.19, 126.65 (d, 3J = 5.03 Hz), 125.44, 123.69 (d, 1J = 273.11 Hz, CF3), 121.83 (d, 2J = 29.82 Hz), 56.57, 45.19, 25.74. HRMS calcd. for C13H17F3NO3S ([M + H]+): 324.0876, found 324.0866. Data for 3,3-dimethyl-2-oxo-N-(3-(trifluoromethyl)phenyl)butane-1-sulfonamide (P-17): Yield 65%; white solid; m.p. 134.0–136.0 °C. 1H-NMR (600 MHz, DMSO-d6) δ10.31 (s, 1H, SO2-NH), 7.58 (t, J = 8.2 Hz, 1H, C6H4-H), 7.56–7.51 (m, 2H, C6H4-H), 7.48–7.43 (m, 1H, C6H4-H), 4.62 (s, 2H, SO2-CH2), 1.04 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 206.01, 137.16, 132.06 (d, 2J = 32.9 Hz), 130.23, 125.43, 123.52 (d, 1J = 272,87 Hz, CF3)122.78 (d, 3J = 3.9 Hz), 118.83 (d, 3J = 3.8 Hz), 53.42, 45.47, 25.50. HRMS calcd. for C13H17F3NO3S ([M + H]+): 324.0876, found 324.0877. Data for 3,3-dimethyl-2-oxo-N-(4-(trifluoromethoxy)phenyl)butane-1-sulfonamide (P-18): Yield 27%; white solid; m.p. 119.3–120.1 °C. 1H-NMR (600 MHz, DMSO-d6) δ 10.12 (s, 1H, SO2-NH), 7.38–7.30 (m, 4H, C6H4-H), 4.56 (s, 2H, SO2-CH2), 1.04 (s, 9H, CH3).13C-NMR (151 MHz, DMSO-d6) δ 204.27, 144.31, 137.13, 122.08, 121.12, 120.07 (q, 1J = 256.08 Hz, CF3), 55.26, 44.69, 25.04. HRMS calcd. for C13H17F3NO4S ([M + H]+): 340.0825, found 340.0833. Data for N-(4-chloro-2-fluorophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-19): Yield 71%; white solid; m.p. 115.3–117.1 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.75 (s, 1H, SO2-NH), 7.51 (dd, J = 10.3, 2.4 Hz, 1H, C6H4-H), 7.44 (t, J = 8.6 Hz, 1H, C6H4-H), 7.28 (m, 1H, C6H4-H), 4.61 (s, 2H, SO2-CH2), 1.08 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.23, 155.45 (d, 1J = 251.09 Hz, F-Ph), 130.24 (d, 3J = 9.60 Hz), 127.51, 124.85 (d, 3J = 3.59 Hz), 124.08 (d, 2J = 12.73 Hz), 116.65 (d, 2J = 23.80 Hz), 57.06, 44.61, 25.23. HRMS calcd. for C12H16ClFNO3S ([M + H]+): 308.0518, found 308.0516. Data for N-(4-bromo-2-fluorophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-20): Yield 55%; white solid; m.p. 113.5–114.7 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.76 (s, 1H, SO2-NH), 7.62 (dd, J = 10.0, 2.0 Hz, 1H, C6H4-H), 7.45–7.37 (m, 2H, C6H4-H), 4.60 (d, J = 27.3 Hz, 2H, SO2-CH2), 1.08 (d, J = 0.9 Hz, 9H, CH3).13C-NMR (151 MHz, DMSO-d6) δ 205.04, 154.12 (d, 1J = 250.99 Hz, F-Ph), 128.25 (d, 3J = 3.70 Hz), 125.30, 123.85 (d, 2J = 12.50 Hz), 119.52 (d, 2J = 22.65 Hz), 118.83 (d, 3J = 8.89 Hz), 54.60, 45.33, 25.63. HRMS calcd. for C12H16BrFNO3S ([M + H]+):352.0013, found 352.0012. Data for N-(2-fluoro-5-(trifluoromethyl)phenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-21): Yield 63%; white solid; m.p. 113.7–115.1 °C. 1H-NMR (600 MHz, DMSO-d6) δ 10.04 (s, 1H, SO2-NH), 7.76 (dd, J = 7.2, 2.3 Hz, 1H, C6H4-H), 7.64 (dt, J = 7.0, 3.2 Hz, 1H, C6H4-H), 7.53 (t, J = 9.3 Hz, 1H, C6H4-H), 4.72 (s, 2H, SO2-CH2), 1.09 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.25, 157.02 (d, 1J = 253.Hz, F-Ph), 126.09 (d, 2J = 13.74 Hz), 125.46 (dq, 2J = 32.46 Hz), 123.87 (q, 3J = 4.06 Hz), 123.53 (q, 1J = 272.02 Hz, CF3), 122.40 (q, 3J = 3.40 Hz) 117.32 (d, 2J = 21.62 Hz), 57.46, 44.62, 25.16. HRMS calcd. for C13H16F4NO3S ([M + H]+): 342.0782, found 342.0780. Data for N-(4-bromo-3-fluorophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-22): Yield 52%; white solid; m.p. 116.0–117.1 °C. 1H-NMR (600 MHz, DMSO-d6) δ 10.32 (s, 1H, SO2-NH), 7.65 (t, J = 8.4 Hz, 1H, C6H4-H), 7.19 (dd, J = 10., 8 2.5 Hz, 1H, C6H4-H), 7.02 (dd, J = 8.7, 2.5 Hz, 1H, C6H4-H), 4.66 (s, 2H, SO2-CH2), 1.05 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.61, 158.66 (d, 1J = 243.74 Hz, F-Ph), 139.75 (d, 3J = 9.93 Hz), 134.12, 117.09 (d, 3J = 3.22 Hz), 107.71 (d, 2J = 26.32 Hz), 101.95 (d, 2J = 20.88 Hz), 55.87, 45.12, 25.41. EIMS calcd. for C12H16BrFNO3S ([M + H]+): 352.00, found 351.90. Data for N-(4-chloro-2-(trifluoromethyl)phenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-23): Yield 63%; white solid; m.p. 127.4–128.7 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.50 (s, 1H, SO2-NH), 7.80 (s, 1H, C6H4-H), 7.83–7.76 (m, 1H, C6H4-H), 7.66 (dd, J = 8.7, 3.2 Hz, 1H, C6H4-H), 4.71 (d, J = 3.0 Hz, 2H, SO2-CH2), 1.10 (d, J = 3.8 Hz, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.43, 133.25, 133.19, 131.46, 131.29, 127.22 (q, 2J = 30.17 Hz), 126.70 (q, 3J = 5.27 Hz), 122.46 (q, 1J = 274.11 Hz, CF3), 58.52, 44.60, 25.27. HRMS calcd. for C13H16ClF3NO3S ([M + H]+): 358.0486, found 358.0487. Data for N-(2-chloro-5-(trifluoromethyl)phenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-24): Yield 9%; white solid; m.p. 97.3–98.5 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.75 (s, 1H, SO2-NH), 7.82 – 7.75 (m, 2H, C6H4-H), 7.62 (dd, J = 8.4, 2.1 Hz, 1H, C6H4-H), 4.77 (s, 2H, SO2-CH2), 1.09 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.40, 135.02, 132.39, 131.04, 128.30 (q, 2J = 32.39 Hz), 123.49 (q, 3J = 3.83 Hz), 123.44 (q, 1J = 272.52 Hz, CF3), 122.89 (q, 3J = 3.96 Hz), 58.36, 44.57, 25.25. HRMS calcd. for C13H16ClF3NO3S ([M + H]+): 358.0486, found 358.0487. Data for N-(4-bromo-2-nitrophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-25): Yield 35%; white solid; m.p. 102.4–106.0 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.89 (s, 1H, SO2-NH), 8.25 (d, J = 2.3 Hz, 1H, C6H4-H), 7.96 (dd, J = 8, 82.3 Hz, 1H, C6H4-H), 7.63 (d, J = 8.8 Hz, 1H, C6H4-H), 4.83 (s, 2H, SO2-CH2), 1.07 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.75, 142.18, 137.27, 130.61, 127.88, 126.86, 116.95, 57.53, 44.63, 25.12. HRMS calcd. for C12H16BrN2O5S([M + H]+ ): 378.9958, found 378.9957. Data for N-(3-bromo-4-fluorophenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-26): Yield 68%; white solid; m.p. 146.9–148.7 °C. 1H-NMR (600 MHz, DMSO-d6) δ 10.06 (s, 1H, SO2-NH), 7.50 (dd, J = 6.1, 2.6 Hz, 1H, C6H4-H), 7.37 (t, J = 8.8 Hz, 1H, C6H4-H), 7.27 (ddd, J = 8.9, 4.3, 2.7 Hz, 1H, C6H4-H), 4.57 (s, 2H, SO2-CH2), 1.06 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.37, 155.13 (d, 1J = 241.60 Hz, F-Ph), 135.25 (d, 3J = 2.97 Hz), 124.57, 121.39 (d, 3J = 7.49 Hz), 117.10 (d, 2J = 23.24 Hz), 108.04 (d, 2J = 22.11 Hz), 55.27, 44.71, 25.06. EIMS calcd. for C12H16BrFNO3S ([M + H]+): 352.00, found 351.90. Data for N-(4-bromo-3-methylphenyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-27): Yield 30%; white solid; m.p. 133.9–134.5 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.97 (s, 1H, SO2-NH), 7.51 (d, J = 8.6 Hz, 1H, C6H4-H), 7.18 (d, J = 2.6 Hz, 1H, C6H4-H), 7.00 (dd, J = 8.6, 2.7 Hz, 1H, C6H4-H), 4.52 (s, 2H, SO2-CH2), 2.30 (s, 3H, ph-CH3), 1.04 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 206.11, 139.85, 139.36, 134.53, 123.88, 121.06, 120.38, 57.00, 46.62, 27.00, 24.54. EIMS calcd. for C13H19BrNO3S ([M + H]+): 348.02, found 347.90. Data for 3,3-dimethyl-2-oxo-N-(2,4,5-trifluorophenyl)butane-1-sulfonamide (P-28): Yield 21%; white solid; m.p. 114.1–115.4°C. 1H-NMR (600 MHz, DMSO-d6) δ 9.84 (s, 1H, SO2-NH), 7.65 (td, J = 10.4, 7.3 Hz, 1H, C6H4-H), 7.51 (dt, J = 11.5, 7.9 Hz, 1H, C6H4-H), 4.66 (s, 2H, SO2-CH2), 1.08 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 205.13, 148.28 (qd, 1J = 244.26 Hz, F-Ph), 147.69 (dq, 1J = 250,84 Hz, F-Ph) 120.63–120.51 (m), 113.34 (d, 2J = 19.70 Hz), 105.79 (d, 2J = 21.79 Hz), 105.70 (d, 2J = 21.85), 54.81, 45.35, 25.60. HRMS calcd. for C12H15Cl3NO3S ([M + H]+): 310.0719, found 310.0719. Data for 3,3-dimethyl-2-oxo-N-(2,4,5-trichlorophenyl)butane-1-sulfonamide (P-29): Yield 62%; white solid; m.p. 144.3–115.2 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.70 (s, 1H, SO2-NH), 7.93 (s, 1H, C6H4-H), 7.73 (s, 1H, C6H4-H), 4.78 (s, 2H, SO2-CH2), 1.10 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 207.17, 137.04, 133.50, 132.77, 131.39, 130.59, 130.02, 61.02, 47.31, 28.00. HRMS calcd. for C12H15F3NO3S ([M + H]+): 357.9833, found 357.9829. Data for 3,3-dimethyl-2-oxo-N-(2,4,6-tribromophenyl)butane-1-sulfonamide (P-30): Yield 9%; white solid; m.p. 135.6–137.6 °C. 1H-NMR (600 MHz, DMSO-d6) δ 9.61 (s, 1H, SO2-NH), 8.02 (s, 2H, C6H4-H), 4.78 (s, 2H, SO2-CH2), 1.13 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.94, 202.64, 136.08, 135.09, 134.83, 129.43, 127.72, 122.06, 61.57, 44.89, 25.94, 25.49. HRMS calcd. for C12H15Br3NO3S ([M + H]+): 489.8317, found 489.8315. Data for 3,3-dimethyl-2-oxo-N-phenethylbutane-1-sulfonamide (P-31): Yield 22%; white solid; m.p. 73.6–74.4 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.30 (t, J = 7.6 Hz, 2H, C6H5-H), 7.26 – 7.19 (m, 3H, C6H5-H), 7.17 (t, J = 5.8 Hz, 1H, SO2-NH)), 4.40 (s, 2H, SO2-CH2), 3.23–3.18 (m, 2H, N-CH2), 2.77 (dd, J = 8.7, 6.7 Hz, 2H, CH2), 1.08 (s, 9H, CH3). 13C-NMR (151 MHz, DMSO-d6) δ 204.99, 138.89, 128.70, 128.30, 126.21, 56.07, 44.58, 44.13, 35.71, 25.24. HRMS calcd. for C14H22NO3S ([M + H]+): 284.1315, found 284.1319. Data for 3,3-dimethyl-N-(4-nitrophenethyl)-2-oxobutane-1-sulfonamide (P-32): Yield 9%; yellow solid; m.p. 92.3–98.5 °C. 1H-NMR (600 MHz, DMSO-d6) δ 8.18 (d, 2H, C6H4-2H), 7.55 (d,1H, 2H, C6H4-2H), 7.24 (s, 1H, SO2-NH), 4.45 (s, 2H, CH2-SO2), 3.33 (s, 2H, NH-CH2), 2.93 (t, 2H, C6H4-CH2), 1.09 (s, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 205.98, 146.90, 145.51, 129.70, 129.01, 128.10, 123.82, 54.74, 45.30, 44.00, 36.28, 26.84, 25.48. HRMS calcd. for C14H21N2O5S ([M + H]+): 329.1171, found 329.1166. Data for 3,3-dimethyl-N-(4-methylphenethyl)-2-oxobutane-1-sulfonamide (P-33): Yield 24%; white solid; m.p. 78.6–79.8 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.13 (m, 5H, C6H4 + SO2-NH), 4.37 (s, 2H, CH2-SO2), 3.18 (m, 2H, NH-CH2), 2.74 (t, 2H, C6H4-CH2), 2.27 (s, 3H, C6H4-CH3), 1.09 (d, 9H, 3CH3).13C-NMR (151 MHz, CDCl3) δ 205.75, 136.29, 134.68, 129.33, 128.64, 54.78, 45.18, 44.87, 35.84, 25.52, 20.95. HRMS calcd. for C15H23NO3NaS ([M + Na]+): 320.1296, found 320.1297. Data for N-(4-methoxyphenethyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-34): Yield 11%; white solid; m.p. 88.9–89.8 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.14 (t, 3H, C6H4-3H), 6.86 (d, 2H, C6H4-H + SO2-NH), 4.36 (s, 2H, CH2-SO2), 3.72 (s, 3H, CH3O), 3.15 (m, 2H, NH-CH2), 2.70 (t, 2H, C6H4-CH2), 1.08 (s, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 205.85, 158.51, 129.83, 129.79, 114.17, 55.28, 54.77, 45.29, 45.06, 35.48, 25.62. HRMS calcd. for C15H23NO4NaS ([M + Na]+): 336.1245, found 336.1242. Data for N-(3-methoxyphenethyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-35): Yield 5%; white solid; m.p. 52.3–53.8 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.21 (t, 1H, C6H4-H), 7.15 (t, 1H, C6H4-H), 6.81–6.77 (m, 3H, C6H4-2H + SO2-NH), 4.39 (s, 2H, CH2-SO2), 3.74 (s, 3H, CH3O), 3.20 (m, 2H, NH-CH2), 2.74 (t, 2H, C6H4-CH2), 1.08 (s, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 205.76, 159.76, 139.34, 129.67, 120.98, 114.39, 112.23, 55.10, 54.78, 45.19, 44.65, 36.33, 25.51. HRMS calcd. for C15H23NO4NaS ([M + Na]+): 336.1245, found 336.1248. Data for N-(3,4-dimethoxyphenethyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-36): Yield 3%; yellow solid; m.p. 93.8–95.6 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.12 (t, 1H, C6H4-H), 6.85 (m, 2H, C6H4-2H), 6.74 (dd, 1H, C6H4-H), 4.36 (s, 2H, CH2-SO2), 3.73 (d, 6H, 2CH3O), 3.19 (m, 2H, NH-CH2), 2.70 (t, 2H, C6H4-CH2), 1.07 (s, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 205.79, 148.94, 147.77, 130.30, 120.69, 111.95, 111.34, 55.82, 55.77, 54.85, 45.17, 44.83, 35.83, 25.47. HRMS calcd. for C16H25NO5NaS ([M + Na]+): 366.1351, found 366.1054. Data for N-(4-fluorophenethyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-37): Yield 10%; yellow solid; m.p. 81.0–83.6 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.28 (dd, 2H, C6H4-2H), 7.17 (t, 1H, SO2-NH), 7.13 (t, 2H, C6H4-2H), 4.41 (s, 2H, CH2-SO2), 3.20 (m, 2H, NH-CH2), 2.77 (t, 2H, C6H4-CH2), 1.09 (d, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 205.86, 162.51, 160.89 (s,1J = 244.62), 133.44, 130.22, 130.21, 115.52, 115.38, 54.71, 45.23, 44.76, 35.52, 25.50. HRMS calcd. for C14H20FNO3NaS ([M + Na]+): 324.1046, found 324.1040. Data for N-(3-fluorophenethyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-38): Yield 7%; yellow solid; m.p. 47.4–52.2 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.34 (td, 1H, C6H4-H), 7.18 (t, 1H, C6H4-H), 7.09 (m, 2H, C6H4-2H), 7.04 (td, 1H, SO2-NH), 4.42 (s, 2H, CH2-SO2), 3.23 (td, 2H, NH-CH2), 2.80 (t, 2H, C6H4-CH2), 1.09 (s, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 205.85, 163.65, 162.02 (s,1J = 246.13), 140.37, 140.32, 130.15, 130.10, 124.45, 124.43, 115.73, 115.58, 113.73, 113.59, 54.80, 45.22, 44.43, 36.06, 36.05, 28.36, 25.50. HRMS calcd. for C14H20FNO3NaS ([M + Na]+): 324.1046, found 324.1042. Data for N-(2-fluorophenethyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-39): Yield 13%; white solid; m.p. 69.8–73.0 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.34 (td, 1H, C6H4-H), 7.28 (dq, 2H, C6H4-2H), 7.16 (m, 2H, C6H4-H + SO2-NH), 4.43 (d, 2H, CH2-SO2), 3.21 (d, 2H, NH-CH2), 2.82 (t, 2H, C6H4-CH2), 1.09 (d, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 205.79, 161.97, 160.34 (s,1J = 245.54), 131.18, 131.15, 128.65, 128.60, 124.72, 124.61, 124.23, 124.21, 115.47, 115.32, 54.73, 45.21, 43.39, 43.38, 29.97, 29.96, 25.53. HRMS calcd. for C14H20FNO3NaS ([M + Na]+): 324.1046, found 324.1043. Data for N-(3-bromophenethyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-40): Yield 22%; yellow solid; m.p. 79.8–81.0 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.48 (d, 1H, C6H4-H), 7.42 (m, 1H, C6H4-H), 7.27 (m, 2H, C6H4-2H), 7.19 (t, 1H, SO2-NH), 4.42 (s, 2H, CH2-SO2), 3.22 (td, 2H, NH-CH2), 2.78 (t, 2H, C6H4-CH2), 1.09 (s, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 205.94, 140.21, 131.87, 130.30, 130.00, 127.54, 122.72, 54.83, 45.34, 44.55, 36.09, 25.60. HRMS calcd. for C14H20BrNO3NaS ([M + Na]+): 384.0245, found 384.0242. Data for N-(2-bromobenzyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-41): Yield 33%; yellow solid; m.p. 79.5–83.4 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.76 (t, 1H, SO2-NH), 7.61 (dd, 1H, C6H4-H), 7.55 (m, 1H, C6H4-H), 7.42 (td, 1H, C6H4-H), 7.24 (td, 1H, C6H4-H), 4.55 (s, 2H, CH2-SO2), 4.28 (d, 2H, NH-CH2), 1.10 (s, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 205.73, 135.80, 133.09, 130.65, 129.84, 127.87, 123.87, 55.96, 47.78, 45.09, 25.72. HRMS calcd. for C13H18BrNO3NaS ([M + Na]+): 370.0088, found 370.0084. Data for N-(2- fluorobenzyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-42): Yield 20%; white solid; m.p. 101.1–103.4 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.74 (t, 1H, SO2-NH), 7.54 (m, 1H, C6H4-H), 7.45 (dd, 1H, C6H4-H), 7.38 (td, 1H, C6H4-H), 7.32 (td, 1H, C6H4-H), 4.54 (s, 2H, CH2-SO2), 4.30 (d, 2H, NH-CH2), 1.10 (s, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 205.68, 134.01, 133.75, 130.42, 129.72, 129.54, 127.15, 55.76, 45.44, 44.99, 25.62. HRMS calcd. for C13H19FNO3S ([M + H]+): 288.1070, found 288.1072. Data for N-(4-fluorobenzyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-43): Yield 11%; white solid; m.p. 129–133.8 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.83 (t, 1H, SO2-NH), 7.73 (d, 2H, C6H4-2H), 7.58 (d, 2H, C6H4-2H), 4.49 (s, 2H, CH2-SO2), 4.30 (d, 2H, NH-CH2), 1.09 (s, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 206.10, 140.38, 130.20, 128.26, 125.69 (q, J = 3.7 Hz), 124.72, 122.92 (s,1J = 271.8), 55.31, 46.95, 45.22, 25.50. HRMS calcd. for C13H19FNO3S ([M + H]+): 288.1070, found 288.1075. Data for N-(4-chlorobenzyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-44): Yield 23%; white solid; m.p. 104.8–108.0 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.73 (t, 1H, SO2-NH), 7.42 (d, 2H, C6H4-2H), 7.37 (d, 2H, C6H4-2H), 4.44 (s, 2H, CH2-SO2), 4.19 (d, 2H, NH-CH2), 1.08 (s, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 206.11, 134.83, 133.91, 129.46, 128.87, 55.37, 46.83, 45.17, 25.53. HRMS calcd. for C13H18ClNO3NaS ([M + Na]+): 326.0594, found 326.0585. Data for N-(4-cyanobenzyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-45): Yield 13%; white solid; m.p. 118.8–120.5 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.84 (dd, 3H, SO2-NH+ C6H4-2H), 7.55 (d, 2H, C6H4-2H), 4.52 (s, 2H, CH2-SO2), 4.30 (d, 2H, NH-CH2), 1.10 (s, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 206.09, 141.99, 132.47, 128.43, 118.39, 111.81, 55.43, 46.84, 45.29, 25.51. HRMS calcd. for C14H19N2O3S ([M + H]+): 295.1116, found 295.1111. Data for N-(2,5-dimethoxybenzyl)-3,3-dimethyl-2-oxobutane-1-sulfonamide (P-46): Yield 29%; white solid; m.p. 58.6–60.8 °C. 1H-NMR (600 MHz, DMSO-d6) δ 7.39 (t, 1H, SO2-NH), 6.96 (d, 1H, C6H4-H), 6.90 (d, 1H, C6H4-H), 6.81 (dd, 1H, C6H4-H), 4.40 (s, 2H, CH2-SO2), 4.18 (d, 2H, NH-CH2), 3.72 (d, 6H, 3OCH3), 1.06 (d, 9H, 3CH3). 13C-NMR (151 MHz, CDCl3) δ 205.45, 153.27, 151.60, 125.11, 116.01, 113.71, 111.09, 55.77 (d, J = 6.6 Hz), 55.53, 44.67, 44.39, 25.63. HRMS calcd. for C15H23NO5NaS ([M + Na]+): 352.1195, found 352.1193.

3.3. Fungicidal Activity Bioassays

The antifungal activity of the compounds was evaluated by a mycelial growth experiment, a tomato pot experiment, and a strawberry experiment. Mycelium Growth Experiments. The method is given in reference [24]. The culture media was potato dextrose agar (PDA). The final concentrations of compounds was 50 mg/L on PDA, and each treatment was repeated three times. Boscalid was used as positive control while acetone was used as blank control. The pathogen cake (5.00mm) was inoculated in the center of PDA culture dish for 5 days. The inhibition rate I (%) was calculated according to following formula:I (%) = [(C − T)/(C − 5)] × 100% C is the average fungal mycelium diameters of the blank control (mm); T is the average fungal mycelium diameters of the treatment (mm). Tomato Pot Experiment. The method is given in reference [25]. The compound tested (200 mg/L) was evenly sprinkled on the tomato seedlings, and a spore suspension was inoculated 24 h later. Each treatment was repeated three times. When the rate of diseased leaves in the blank control reached more than 50%, the classification investigation was carried out. The inhibition rate I (%) was calculated according to the following formula:X = [∑(Ni × i)/(N × 9)] × 100% where X is the disease index, Ni the number of diseased leaves, i the disease grade and N the total leaves investigated. I (%) = [(CX − TX)/(CX − 5)] × 100% CX is the average disease index of the blank control; TX is the average disease index of the treatment. Strawberry Experiment. The method is given in reference [25]. The compound to be tested (400 mg/L) was evenly sprinkled on the strawberries, and the spore suspension was inoculated 24 h later. Each treatment was repeated three times. When the disease spot diameter of the blank control was greater than 30 mm, the investigation wase carried out. The inhibition rate I (%) was calculated according to the following formula:I (%) = [(CM − TM)/CM] × 100% CM is the average lesion diameters of the blank control (mm); TM is the average lesion of the treatment (mm).

4. Conclusions

In summary, 46 pinacolone sulfonamides were designed and synthesized, and presented excellent antifungal activity against a variety of plant pathogenic fungi, especially Botrytis cinerea. The high activity compound P-29 was screened by biological activity evaluation and presented superb inhibition efficacy. Compound P-29 has high research value and great potential to be developed as the novel lead compound in the design of a new pesticide.
  12 in total

1.  Synthesis, fungicidal activity, and structure-activity relationship of 2-oxo- and 2-hydroxycycloalkylsulfonamides.

Authors:  Xing-Hai Li; De-Cai Wu; Zhi-Qiu Qi; Xiu-Wei Li; Zu-Min Gu; Song-Hong Wei; Yang Zhang; Ying-Zi Wang; Ming-Shan Ji
Journal:  J Agric Food Chem       Date:  2010-10-07       Impact factor: 5.279

Review 2.  Wicked evolution: Can we address the sociobiological dilemma of pesticide resistance?

Authors:  Fred Gould; Zachary S Brown; Jennifer Kuzma
Journal:  Science       Date:  2018-05-18       Impact factor: 47.728

3.  Botrytis spp.: A Contemporary Perspective and Synthesis of Recent Scientific Developments of a Widespread Genus that Threatens Global Food Security.

Authors:  Jonathan K Richards; Chang-Lin Xiao; Wayne M Jurick
Journal:  Phytopathology       Date:  2021-02-10       Impact factor: 4.025

4.  Development of Boscalid Resistance in Botrytis cinerea and an Efficient Strategy for Resistance Management.

Authors:  Kaidi Cui; Leiming He; Tongtong Li; Wei Mu; Feng Liu
Journal:  Plant Dis       Date:  2021-02-22       Impact factor: 4.438

5.  Perspective: present pesticide discovery paradigms promote the evolution of resistance - learn from nature and prioritize multi-target site inhibitor design.

Authors:  Jonathan Gressel
Journal:  Pest Manag Sci       Date:  2019-11-12       Impact factor: 4.845

6.  Synthesis, fungicidal activity and SAR of 3,4-dichloroisothiazole-based cycloalkylsulfonamides.

Authors:  Yumeng Zhang; Minlong Wang; Maqsood Ahmed; Lu He; Mingshan Ji; Zhiqiu Qi; Xinghai Li
Journal:  Bioorg Med Chem Lett       Date:  2019-03-29       Impact factor: 2.823

7.  Synthesis and biological activities of 2-oxocycloalkylsulfonamides.

Authors:  Xinghai Li; Xinling Yang; Xiaomei Liang; Zhenpeng Kai; Huizu Yuan; Dekai Yuan; Jianjun Zhang; Ruiqing Wang; Fuxiang Ran; Shuhua Qi; Yun Ling; Fuheng Chen; Daoquan Wang
Journal:  Bioorg Med Chem       Date:  2008-02-16       Impact factor: 3.641

8.  Fungicide Resistance Profiles of Botrytis cinerea Isolates From Michigan Vineyards and Development of a TaqMan Assay for Detection of Fenhexamid Resistance.

Authors:  S A Alzohairy; J Gillett; S Saito; R N Naegele; C L Xiao; T D Miles
Journal:  Plant Dis       Date:  2021-01-04       Impact factor: 4.438

9.  Advances in understanding fungicide resistance in Botrytis cinerea in China.

Authors:  Wenyong Shao; Youfu Zhao; Zhonghua Ma
Journal:  Phytopathology       Date:  2020-11-11       Impact factor: 4.025

10.  Design, Synthesis and Fungicidal Activity of 2-Substituted Phenyl-2-oxo-, 2-Hydroxy- and 2-Acyloxyethylsulfonamides.

Authors:  Minlong Wang; Peng Rui; Caixiu Liu; Ying Du; Peiwen Qin; Zhiqiu Qi; Mingshan Ji; Xinghai Li; Zining Cui
Journal:  Molecules       Date:  2017-05-04       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.